By combining our expertise in molecular self-assembly and surface chemistry with innovative transduction technologies, we develop new strategies for biomolecular interaction analysis. In particular we exploit colloidal gold nanoparticles in various sizes and shapes for nanoplasmonic detection of disease biomarkers, protein drugs and toxins. Using designed peptide-based synthetic receptors, robust and sensitive detection can be achieved.